...
首页> 外文期刊>Gastrointestinal Endoscopy >Long-term outcomes associated with pancreatic extracorporeal shock wave lithotripsy for chronic calcific pancreatitis
【24h】

Long-term outcomes associated with pancreatic extracorporeal shock wave lithotripsy for chronic calcific pancreatitis

机译:胰腺体外冲击波碎石术治疗慢性钙化性胰腺炎的长期预后

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Background: Most outcomes data on pancreatic extracorporeal shock wave lithotripsy (P-ESWL) for chronic calcific pancreatitis (CCP) are based on studies with <4 years' follow-up, and U.S. long-term studies are lacking. Objective: To report long-term P-ESWL outcomes for CCP and to assess whether smoking or alcohol use influences P-ESWL outcomes. Design: Cross-sectional study, retrospective chart review. Setting: Virginia Mason Medical Center, Seattle, Washington. Patients: This study involved 120 patients who underwent P-ESWL and ERCP for CCP and completed an outcomes questionnaire. Intervention: P-ESWL and ERCP, outcomes survey. Main Outcome Measurements: Pain, quality of life, narcotics use, diabetes status, pancreatic enzyme requirement, repeat P-ESWL, repeat ERCP, surgery. Results: A total of 120 patients underwent P-ESWL followed by ERCP (mean ± standard deviation [SD] follow-up 4.3 [± 3.7] years) and completed a survey. The mean (± SD) before-P-ESWL pain score was 7.9 (± 2.6) compared with 2.9 (± 2.6) after P-ESWL (P <.001). Improved pain was reported by 102 patients (85%); 60 (50%) reported complete pain relief and no narcotic use. The mean (± SD) before-P-ESWL quality-of-life score was 3.7 (± 2.4) compared with 7.3 (± 2.7) after P-ESWL (P <.001). In patients with <4 years' follow-up, repeat procedures included P-ESWL (29%), ERCP (84%), and surgery (16%). Smokers who quit smoking after P-ESWL had improved narcotic requirements compared with those who continued smoking (95% vs 67%; P =.014), and a trend suggested a decreased need for repeat ERCPs (68% vs 84%; P =.071). Limitations: Single center, retrospective, recall bias, nonvalidated pain and quality-of-life scales. Conclusion: P-ESWL as the initial therapy for CCP may lead to more lifetime procedures; however, partial pain relief in 85%, complete pain relief with no narcotic use in 50%, and avoidance of surgery in 84% of patients may be achieved. Quitting smoking after P-ESWL may improve outcomes.
机译:背景:关于慢性钙化性胰腺炎(CCP)的胰腺体外冲击波碎石术(P-ESWL)的大多数结果数据都是基于随访不到4年的研究,并且缺乏美国的长期研究。目的:报告CCP的长期P-ESWL结果,并评估吸烟或饮酒是否会影响P-ESWL结果。设计:横断面研究,回顾性图表审查。地点:华盛顿州西雅图市弗吉尼亚梅森医疗中心。患者:这项研究涉及120例接受CCP的P-ESWL和ERCP的患者,并完成了结果问卷。干预:P-ESWL和ERCP,结果调查。主要指标:疼痛,生活质量,麻醉药物使用,糖尿病状况,胰腺酶需求量,重复P-ESWL,重复ERCP,手术。结果:总共120例患者接受了P-ESWL,随后接受了ERCP(平均随访±4.3年[±3.7]年),并完成了一项调查。 P-ESWL疼痛评分的平均值(±SD)为7.9(±2.6),而P-ESWL疼痛评分为2.9(±2.6)(P <.001)。据报道,有102位患者(85%)改善了疼痛。 60(50%)人报告疼痛完全缓解且未使用麻醉药。 P-ESWL之前的生活质量得分的平均值(±SD)为3.7(±2.4),而P-ESWL之后为7.3(±2.7)(P <.001)。随访<4年的患者,重复手术包括P-ESWL(29%),ERCP(84%)和手术(16%)。与继续吸烟者相比,P-ESWL戒烟者的麻醉需求有所改善(95%比67%; P = .014),并且趋势表明重复ERCP的需求减少(68%比84%; P = .071)。局限性:单中心,回顾性,回忆偏倚,未经证实的疼痛和生活质量量表。结论:P-ESWL作为CCP的初始治疗方法可能会导致更多的终生手术。然而,可以实现85%的部分疼痛缓解,50%的不使用麻醉剂的完全疼痛缓解以及84%的患者避免手术。 P-ESWL后戒烟可能会改善结局。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号